Abstract
Background
Acute treatment is associated with improved in‐hospital outcomes for patients with non‐ST‐segment elevation acute coronary syndrome (NSTE ACS).
Hypothesis
Patients who receive appropriate acute treatment are more likely to receive guideline‐recommended therapy at hospital discharge.
Methods
Use of aspirin (ASA), β‐blockers, and clopidogrel was evaluated in the first 24 hours and upon hospital discharge according to the 2002 American College of Cardiology/American Heart Association (ACC AHA) guidelines for NSTE ACS. We compared the relationship between 3 groups: (1) ASA therapy given in the emergency department (ED); (2) ASA therapy not given in the ED, but within the first 24 hours; and (3) no acute ASA treatment. The ASA data set includes 10, 468 high risk patients with positive cardiac biomarkers or ischemic ST‐segment changes on ECG from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) Quality Improvement Initiative. β‐Blocker therapy was evaluated in 11, 838 and clopidogrel treatment in 17, 513 patients presenting to over 345 US hospitals.
Results
Patients who received acute ASA in the ED, ASA in the first 24 hours but not in the ED, and patients who did not receive ASA therapy within 24 hours had discharge ASA treatment rates of 91.8%, 91.4%, and 55.6%, respectively (P < 0.0001). Patients eligible for β‐blocker and clopidogrel therapy had discharge β‐blocker treatment rates of 91.1%, 92.4%, and 46.6% (P < 0.0001), and discharge clopidogrel treatment rates of 86.6%, 92.4%, and 38.5% (P < 0.0001), respectively.
Conclusions
Acute treatment for NSTE ACS in‐hospital is associated with appropriate treatment on hospital discharge. This link between early treatment and discharge therapy may lead to new approaches ensuring the delivery of high‐quality, guideline‐based care for patients with NSTE ACS. Copyright © 2009 Wiley Periodicals, Inc.
Full Text
The Full Text of this article is available as a PDF (506.2 KB).
References
- 1. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guidelines for management of patients with unstable angina and non‐ST elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). Circulation 2002; 106(14): 1893–1900. [DOI] [PubMed] [Google Scholar]
- 2. Hoekstra JW, Pollack CV Jr., Roe MT, et al. Improving the care of patients with non‐ST‐elevation acute coronary syndromes in the emergency department: the CRUSADE initiative. Acad Emerg Med 2002; 9(11): 1146–1155. [DOI] [PubMed] [Google Scholar]
- 3. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non‐ST‐elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non‐ST‐Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 2007; 50(7): e1–e157. [DOI] [PubMed] [Google Scholar]
- 4. Roe MT, Ohman EM, Pollack CV, et al. Changing the model of care for patients with acute coronary syndromes: implementing practice guidelines and altering physician behavior. Am Heart J 2003; 146(4): 605–612. [DOI] [PubMed] [Google Scholar]
- 5. Antman EM, Sacks DB, Rifai N, McCabe CH, Cannon CO, Braunwald E. Time to positivity of a rapid bedside assay for cardiac‐specific troponin I predicts prognosis in acute coronary syndromes: a Thrombolysis in Myocardial Infarction (TIMI) 11A substudy. J Am Coll Cardiol 1998; 31(2): 326–330. [DOI] [PubMed] [Google Scholar]
- 6. Roe MT, Chen AY, Mehta RH, et al. Influence of inpatient service specialty on care processes and outcomes for patients with non‐ST‐segment elevation acute coronary syndromes. Circulation 2007; 116(10): 1153–1161. [DOI] [PubMed] [Google Scholar]
- 7. Mehta RH, Roe MT, Chen AY, et al. Recent trends in the care of patients with non‐ST‐segment elevation acute coronary syndromes: insights from the CRUSADE initiative. Arch Intern Med 2006; 166(18): 2027–2034. [DOI] [PubMed] [Google Scholar]
- 8. Peterson ED, Roe MT, Mulgund J, et al. Association between hospital process performance and outcomes among patients with acute coronary syndromes. JAMA 2006; 295(16): 1912–1920. [DOI] [PubMed] [Google Scholar]
- 9. Gattis WA, O'Connor CM, Gallup DS, Hasselblad V, Gheorghiade M. Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT‐HF) trial. J Am Coll Cardiol 2004; 43(9): 1534–1541. [DOI] [PubMed] [Google Scholar]